Skip to main content
European Commission logo
Enterprise Europe Network

Technologies sampling the interstitial fluid in skin

Summary

Closed for EoI
Profile Type
  • Technology request
POD Reference
TRBE20240717022
Term of Validity
17 July 2024 - 17 July 2025
Company's Country
  • Belgium
Type of partnership
  • Commercial agreement with technical assistance
Targeted Countries
  • All countries
Contact the EEN partner nearest to you for more information.
Find my local partner

General information

Short Summary
A Belgian multinational active in the consumer goods is seeking technologies sampling the interstitial fluid in skin. The Belgian company is looking for collaboration with industrial partners or academia able to provide the required solution. The kind of expected collaboration is a commercial agreement with technical assistance or a licence agreement allowing the large account envisage discussions on the terms of the licence use
Full Description
Interstitial fluid (ISF), the fluid in spaces between the cells, is a novel source of biomarkers that compliments conventional sources like blood and urine.
The use of ISF for therapeutic drug monitoring, dermatological diagnoses and continuous biomarker measurements provides unique information and is potentially pain-free. Despite the advantages, ISF has received limited attention due to the lack of simple collection methods.

Thus, there is a need for a simple ISF collection method.

This company is looking for these technolgies so as to provide its customers with more effective products and enhanced experiences while using those products.
Technical Specification or Expertise Sought
The company would like to access interstitial fluid solution to advance discovery of novel biomarkers related to skin health and whole-body health and enable them to use ISF for monitoring delivery/bioavailability of actives and sensing and demoing product efficacy (first use benefit).

With such a purpose, the company is looking for technologies sampling the interstitial fluid in skin which are:

- Minimally invasive – No hypodermic needles or large instrumentation needed.
- Simple – Allow for simple, point-of-care collection of ISF.
- Quick – Collection can be done within minutes in clinic or at home.
- Clean – Blood-free
- Compliant – Safety and regulatory clearance for use
- Flexible – Easy to be integrated with microfluidic, lateral flow, or electrochemical device.

The company is NOT looking for:

• Tape strips, swabs, and other techniques that only sample stratum corneum.
• Invasive techniques that involve blood.
Stage of Development
  • Already on the market
Sustainable Development Goals
  • Goal 3: Good Health and Well-being
IPR status
  • IPR granted
IPR notes
Please note that only non-confidential information describing the business & services model, current use and IP can be accepted for review.

Partner Sought

Expected Role of a Partner
Type of partner sought : industrial player or academia

Role of the partner: collaborate with the large account with a view to reach a win-win agreement on the solution the large account is looking for
Type and Size of Partner
  • R&D Institution
  • SME 50 - 249
  • SME 11-49
Type of partnership
  • Commercial agreement with technical assistance

Dissemination

Technology keywords
  • 03010 - Household Goods & Appliances
  • 03004009 - Soaps, detergents
  • 03004011 - Care, Hygiene, Beauty
Market keywords
  • 07004008 - Other consumer products
  • 07005006 - Other consumer services (including photo processing)
Sector Groups Involved
  • Health
Targeted countries
  • All countries